Detalles de la búsqueda
1.
Development and validation of a prognostic score to identify the optimal candidate for preemptive TIPS in patients with cirrhosis and acute variceal bleeding.
Hepatology
; 79(1): 118-134, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594323
2.
Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial.
Hepatology
; 76(3): 676-688, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35266571
3.
Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding.
Hepatology
; 73(4): 1478-1493, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32706906
4.
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.
Eur Radiol
; 32(9): 5799-5810, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35381853
5.
Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
Am J Gastroenterol
; 116(7): 1447-1464, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33630766
6.
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.
Invest New Drugs
; 38(5): 1247-1256, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31832851
7.
Long-term results of variceal bleeding management in 302 patients with chronic extrahepatic portal vein obstruction.
J Gastroenterol Hepatol
; 35(6): 1049-1056, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31677186
8.
Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.
J Gastroenterol Hepatol
; 35(7): 1215-1222, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711259
9.
Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.
Gut
; 68(7): 1297-1310, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30415233
10.
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC.
Invest New Drugs
; 37(3): 401-414, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019101
11.
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.
BMC Cancer
; 19(1): 409, 2019 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31039750
12.
Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
J Vasc Interv Radiol
; 30(2): 148-153.e2, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30638778
13.
Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
Gut
; 67(12): 2156-2168, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28970291
14.
mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib.
Int J Cancer
; 140(2): 390-399, 2017 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27681592
15.
Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
J Hepatol
; 67(3): 508-516, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28506905
16.
Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
Am J Gastroenterol
; 117(1): 200, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34882097
17.
Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.
Radiology
; 285(3): 999-1010, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28682164
18.
Chemoembolization for Hepatocellular Carcinoma in Patients with Extrahepatic Spread: Prognostic Determinants and Appropriate Candidates.
J Vasc Interv Radiol
; 28(7): 956-962, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28420555
19.
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients.
Int J Cancer
; 139(4): 928-37, 2016 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27038145
20.
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
Liver Int
; 36(5): 667-76, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26235541